SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. SWK provides non-dilutive financing to fuel the ...

SWK Holdings offers a 9% coupon baby bond, which is currently trading close to par, making it a good choice for income investors. Despite a decline in revenues, SWK managed to increase its net profit ...

DALLAS, TX / ACCESS Newswire / April 10, 2025 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company, today announced the closing of the ...

SWK Holdings Corporation (NASDAQ:SWKH) Q2 2025 Earnings Call Transcript August 15, 2025 Operator: Greetings. Welcome to the SWK Holdings Second Quarter 2025 Conference Call. [Operator Instructions].

Greetings. Welcome to the SWK Holdings Fourth Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.

Originations: In November, SWK advanced $5.0M to existing borrower Journey Medical to help fund the company’s launch of Emrosi. In November, as part of a broader amendment SWK advanced $0.6M to ...